ArticleAnnals of translational medicine2021
Therapeutic effect of intense pulsed light with optimal pulse technology on meibomian gland dysfunction with and without ocular
Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Advances in Dry Eye Disease Examination Techniques.Frontiers in medicine · 2021Pooled it
- Intense pulsed light as a multi-target intervention paradigm for refractory ocular surface diseases: a review.Eye and vision (London, England) · 2026Review
- Pharmacotherapy ofPharmacy (Basel, Switzerland) · 2025Article
- Patient-Reported Burden of Illness and Unmet Needs inPatient preference and adherence · 2025Article
- Intense Pulsed Light Combined with Low Level Blue and Red Light Therapy forClinical ophthalmology (Auckland, N.Z.) · 2025Article
- Evaluating the role of Demodex infestation and meibomian gland dysfunction in recurrent corneal erosion syndrome.Scientific reports · 2024Article
- Intense pulsed light therapy for ocular surface diseases.Lasers in medical science · 2024Review
- Therapeutic efficacy of optimal pulse technology in the treatment ofFrontiers in medicine · 2023Article
- Uneven Meibomian Gland Dropout in Patients with Meibomian Gland Dysfunction andJournal of clinical medicine · 2022Article
- Therapeutic Effect of Intense Pulsed Light in Patients with Sjögren's Syndrome Related Dry Eye.Journal of clinical medicine · 2022Article
- Current practices and considerations in intense pulsed light therapy for meibomian gland dysfunction.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the therapeutic effect of intense pulsed light (IPL) therapy with optimal pulse technology (OPT) on meibomian gland dysfunction (MGD) with and without ocular
methodsThis prospective study included 150 patients with MGD who were divided into
resultsThe incidence of
conclusionsThis new-generation IPL with OPT treatment results in greater improvement in MG expressibility and meibum quality in MGD patients with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.